CAS: 457657-34-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PA452 REF: 54-BUP05584CAS: 457657-34-0 | ≥95% | 965.00 €~1,737.00 € | Wed 30 Apr 25 |
 | PA 452 REF: TR-P205818CAS: 457657-34-0 | - - - | 11,848.00 € | Tue 10 Jun 25 |
 | PA452 REF: TM-T16425CAS: 457657-34-0 | 96.76% | 92.00 €~1,283.00 € | Tue 01 Jul 25 |
 | PA 452 REF: 3D-HTA65734CAS: 457657-34-0 | Min. 95% | - - - | Discontinued product |
Ref: 54-BUP05584
| 25mg | 965.00 € | ||
| 50mg | 1,268.00 € | ||
| 100mg | 1,737.00 € |
Estimated delivery in United States, on Wednesday 30 Apr 2025
PA 452
Controlled ProductCAS:457657-34-0
Formula:
C26H37N3O3
Color and Shape:
Neat
Molecular weight:
439.59
Ref: TR-P205818
| 50mg | 11,848.00 € |
Estimated delivery in United States, on Tuesday 10 Jun 2025
PA452
CAS:457657-34-0
PA452 is a selective antagonist of retinoic X receptor (RXR) and suppresses the effect of …
Formula:
C26H37N3O3
Purity:
96.76%
Color and Shape:
Solid
Molecular weight:
439.59
Ref: TM-T16425
| 1mg | 92.00 € | ||
| 5mg | 250.00 € | ||
| 10mg | 401.00 € | ||
| 25mg | 657.00 € | ||
| 50mg | 937.00 € | ||
| 100mg | 1,283.00 € | ||
| 1mL*10mM (DMSO) | 274.00 € |
Estimated delivery in United States, on Tuesday 1 Jul 2025
PA 452
CAS:457657-34-0
PA 452 is a synthetic analog of erythromycin, which has been shown to inhibit the …
Formula:
C26H37N3O3
Purity:
Min. 95%
Molecular weight:
439.59 g/mol
Ref: 3D-HTA65734
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information |
